Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 709 Trial in progress: product...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors

709 Trial in progress: product characteristics and clinical trial design for T-Plex, a multiplexed, enhanced T cell receptor-engineered T cell therapy for solid tumors

Bibliographic Details
Main Authors: Yun Wang, Ribhu Nayar, Mollie Jurewicz, Qikai Xu, Yifan Wang, Nancy Nabilsi, Gavin MacBeath, Marlyane Motta, Jim Murray, Debora Barton, Jenny Tadros, Badr Kiaf, Victor Ospina, Alok Das Mahopatra, Tary Traore, Antoine J Boudot, Cagan Gurer, Shrikanta Chattopadhyay, Hannah Bader, Chris Malcuit, Andrew Ferretti, Zhonghua Zhu, Krista Daniels, Briana Zimmerman, Amanda Kordosky, Ray Lockard
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • 390 Discovery of MAGE-A1-specific TCR-T cell therapy candidates to expand multiplex therapy of solid tumors
    by: Jin He, et al.
    Published: (2023-11-01)
  • 364 Non-clinical development of T-Plex component TSC-200-A0201: a natural HPV16 E7-specific TCR-T cell therapy for the treatment of HPV16-positive solid tumors
    by: Kenneth Olivier, et al.
    Published: (2023-11-01)
  • 376 Overcoming tumor heterogeneity – Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1
    by: Yun Wang, et al.
    Published: (2023-11-01)
  • 156 Discovery of TSC-100: A natural HA-1-specific TCR to treat leukemia following hematopoietic stem cell transplant therapy
    by: Kenneth Olivier, et al.
    Published: (2020-11-01)
  • 357 Discovery of a novel MAGEC2 epitope for TCR-T adoptive cell therapy from expanded T cell clones of TIL therapy products
    by: Qikai Xu, et al.
    Published: (2023-11-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs